Objectives: Most work on ischemia-induced neuronal death has revolved around the relative contributions of necrosis and apoptosis, but this work has not accounted for the role of ischemia-induced stress responses. An expanded view recognizes a competition between ischemia-induced damage mechanisms and stress responses in the genesis of ischemia-induced neuronal death. An important marker of postischemic stress responses is inhibition of neuronal protein synthesis, a morphological correlate of which is the compartmentalization of mRNA away from ribosomes in the form of cytoplasmic mRNA granules. Methods: Here we assessed the generality of this mRNA granule response following either 10 or 15 minutes of global brain ischemia and 1 hour of reperfusion, 4 hours of focal cerebral ischemia alone, and endothelin-1 intraventricular injection. Results: Both global and focal ischemia led to prominent neuronal cytoplasmic mRNA granule formation in layer II cortical neurons. In addition, we report here new post-ischemic cellular phenotypes characterized by the loss of nuclear polyadenylated mRNA staining in cortical neurons following endothelin-1 treatment and 15 minutes of global ischemia. Both mRNA granulation and loss of nuclear mRNAs occurred in nonshrunken post-ischemic neurons. Discussion: Where cytoplasmic mRNA granules generally appear to mark a protective response in surviving cells, loss of nuclear mRNAs may mark cellular damage leading to cell atrophy/death. Hence, staining for total mRNA may reveal facets of the competition between stress responses and damage mechanisms at early stages in post-ischemic neurons.
Introduction
Discovering the causes of neuronal demise following ischemia has proven to be a formidable task. In part this is due to the heterogeneity of cell death forms as a function of the type of ischemic insult (global, focal, complete, and incomplete) and in part to the nonmutual exclusivity of pathways 1, 2 and phenotypes 3 leading to necrotic or apoptotic cell death. One conceptual barrier that has stood in the way of developing a comprehensive theory of ischemiainduced neuronal death is the idea that such death is directly caused by ischemia-induced cellular damage. While this is clearly true of prolonged intense ischemic insults, 4 such a view may provide incomplete understanding of delayed forms of neuronal death found after global ischemia and reperfusion or in penumbral neurons following focal ischemia. A key concern with any view in which cell death is thought to be directly caused by damage pathways (be these necrotic or apoptotic) is that such a view assigns an essentially passive role to the affected cells. An expanded point of view, that is gaining increasing appreciation, also includes consideration of the neuron's ability to combat damage following ischemia and reperfusion. [5] [6] [7] In such a view, the affected cells are not passive with respect to the accumulation of damage but actively 'fight back' against the damage. It is well established that post-ischemic neurons, under the appropriate conditions, induce, or try to induce, important intracellular stress responses such as the heat shock response, 8, 9 endoplasmic reticulum stress response pathways 10, 11 and DNA repair pathways. 12, 13 It is possible to formally model the cellular response to ischemia as a bistable competition between induced stress responses and damage mechanisms. 14, 15 If total damage exceeds the cell's total ability to cope, the cell will die. If the cell's stress responses win out over damage mechanisms, the cell survives. This type of model has several advantages as it accounts for: (i) the empirical data under conditions where both damage pathways and stress responses are induced in post-ischemic neurons;
(ii) the delay in cell death as the time required for the competition between damage pathways and stress responses to play out; and (iii) not only why some cells die, but also explains how other neurons can survive the ischemia, e.g., that stress responses successfully combat ischemia-induced damage and facilitate neuronal repair and restoration in ischemiaresistant neurons.
We recently showed that staining for polyadenylated mRNAs using fluorescent in situ hybridization following 10 minutes of global brain ischemia served to mark changes in hippocampal neurons related to stress response induction. 16 In post-ischemic neurons, polyadenylated mRNAs formed a granular pattern that we termed 'mRNA granules'. The mRNA granules correlated with: (i) post-ischemic inhibition of protein synthesis; and (ii) expression of the heat shock response. 16 The occurrence of mRNA granules was reversed after 16 hours of reperfusion in ischemia-resistant CA3 neurons but persisted in ischemiavulnerable CA1 neurons that never recovered normal protein synthesis and died by 72 hours of reperfusion. Thus, we have interpreted the mRNA granules to represent a morphological marker of a genetic reprogramming of post-ischemic neurons into a stress response phenotype. 17 To determine the generality of the mRNA granule responses, we here used polyadenylated mRNA staining to characterize a wider variety of ischemic conditions including global brain ischemia and reperfusion, focal cerebral ischemia, and endothelin-1 intraventricular injection. Endothelin-1 is a small peptide with strong vasoconstrictor properties 18, 19 which plays a role in the regulation of cerebral circulation, 20 and has been used as a means to induce focal brain ischemia by a variety of routes of administration. [21] [22] [23] Both global and focal ischemia led to prominent neuronal cytoplasmic mRNA granule formation in layer II cortical neurons. In addition, we report here new post-ischemic phenotypes characterized by the loss of nuclear polyadenylated mRNA staining in cortical neurons following endothelin-1 treatment and 15 minutes of global ischemia. Both mRNA granulation and loss of nuclear mRNAs occurred in non-shrunken postischemic neurons. Where mRNA granules generally appear to mark a protective response in surviving cells, loss of nuclear mRNAs may mark cellular damage leading to atrophy/death. Hence, staining for total mRNA may reveal facets of the competition between stress responses and damage mechanisms at early stages in post-ischemic neurons.
Materials and Methods Materials
Alexa 488-labeled streptavidin (S32354) was obtained from Invitrogen (Carlsbad, CA, USA 
Animal models
All animal experiments were approved by the Wayne State University Institutional Animal and Care Use Committee and were conducted following the Guide for the Care and Use of Laboratory Animals (National Research Council, revised 1996). All efforts were made to reduce animal suffering and minimize the total number of animals used.
Endothelin-1 treatment
Male Long-Evans rats were anesthetized with ketamine and xylazine (100 and 10 mg/kg, respectively), heads shaved and then symmetrically fixed by ear bars, front teeth, and nosebar into a stereotaxic frame. A 1-inch incision was made down the midline of the scalp and the exposed skull cleared of tissue.
Coordinates for injection into the lateral ventricle were: posterior 20.80 mm, lateral 21.5 mm, ventral 23.8 mm, all relative to Bregma. 24 Bilateral holes were drilled and a 21-guage needle lowered sequentially into the lateral ventricles. Endothelin-1 or vehicle was injected in 10 ml over 10 seconds, and the needle left in place for an additional 1 minute. Endothelin-1 treatment was randomly assigned to animals in five experimental groups: (i) vehicle (normal saline) only; (ii) 100 pg; (iii) 200 pg; (iv) 400 pg; and (v) 800 pg endothelin-1. These injection amounts corresponded to 25, 50, 100, and 200 mM endothelin-1, respectively. Following endothelin-1 injection, rats were released from the stereotaxic frame and the wound sealed by staples. Animals were returned to their cages for 4 hours at which time they were used either for measuring cerebral blood flow (n53 per experimental group) or perfusion fixed for tissue staining (n53-5 per experimental group).
Global brain ischemia and reperfusion
Global forebrain ischemia was induced in male LongEvans rats using the bilateral carotid artery (twovessel) occlusion and hypovolemic hypotension model of Smith et al., 25 as we have previously described. 16, 26, 27 Rats were maintained normothermic during the entire ischemic period and for the first hour of reperfusion. Post-surgical animals displaying necrosis, weight loss .15% initial body weight/day, or sustained seizure activity were excluded from the study. Our overall survival rate for the reperfusion groups was 75%. Experimental groups were: shamoperated, non-ischemic controls, 10 minutes of ischemia and 60 minutes of reperfusion, and 15 minutes of ischemia and 1 hour of reperfusion. There were three animals per each experimental group. At the appropriate time, animals were perfusion fixed as previously described. 16 
Focal brain ischemia
Unilateral focal brain ischemia was induced in male Long-Evans rats using the middle cerebral artery occlusion intraluminal suture model of Hatashita et al., 28 as previously described. [29] [30] [31] This model has been well validated with respect to localized infarct and penumbral development. [29] [30] [31] Rats were maintained normothermic during the entire ischemic period and, where appropriate, for the first hour of reperfusion. Animals undergoing reperfusion were anesthetized in 5% halothane at the end of the ischemic period, followed by removal of the nylon filament. At the end of experimental periods, animals were perfusion fixed as described above. Experimental groups were: shamoperated, non-ischemic controls, 4 hour of ischemia only, and 2 hours of ischemia and 24 hours of reperfusion. There were three animals per each experimental group.
Measurement of cerebral blood flow by magnetic resonance imaging
Prior to image acquisition, anesthesia was induced by a steady application of 1% halothane using a specially designed apparatus compatible with the magnetic resonance imaging to sedate the animals. The animal was placed in a prone position on a cradle with a custom-built palate holder equipped with an adjustable nose cone and stereotaxic ear bars in order to minimize movement during magnetic resonance imaging scans. The rat head was positioned at the isocenter of a magnet. All magnetic resonance imaging measurements were performed on a 4.7-T horizontal bore magnetic resonance spectrometer (Bruker AVANCE) with an 11.6-cm bore actively shielded gradient coil set capable of producing a magnetic field gradient of up to 250 mT/m. A whole-body birdcage radiofrequency coil (inner diameter, 72 mm) was used as the transmitter for homogeneous radio frequency excitation, and a surface coil (30 mm diameter) was used as the receiver, with active radio frequency decoupling to avoid signal interference. Three sequences were run in this set of experiments: T2-weighted imaging, T1-weighted imaging, and arterial spin labeling (ASL) for the measurement of flow.
For all sequences, the field of view was 40640624 mm 3 ; thus, the whole brain was imaged. The remaining imaging parameters used are as follows: T2-weighted imaging rapid acquisition with relaxation enhancement: repetition time (TR)5 4751 ms, echo time (TE)546 ms, matrix size Nx6Ny52566256, number of slices (Ns)524 (thickness, 1 mm), number of acquisitions (Nacq)51; T1-weighted imaging (three-dimension fast low angle shot): TR522 ms, TE57 ms, flip angle558 and 208, matrix size Nx6Ny6Nz 52566256624, Nacq51 (flip angles of 58 and 208 will be used to calculate T1 maps); ASL: TR51550 ms, TE57.65 ms, matrix size Nx6Ny5128670 (interpolated by zero filling in kspace to 256_256), slice51 (thickness, 2 mm), Nacq52, labeling slice52 cm offset from isocenter, adiabatic fast passage with magnetization transfer contrast gradients51.5 s, spin echo53.
Tissue staining
Polyadenylated mRNAs were detected by fluorescence in situ hybridization using a 50-mer poly-T probe as previously described. 16 The Fluoro-Jade procedure was exactly that of Schmued et al. 32 Fluoro-Jade slides were examined using excitation at 488 nm and emission at 518 nm. For middle cerebral artery occlusion samples, 2,3,5-triphenyltetrazolium chloride staining was used to measure tissue viability and evaluate infarct size as previously described. 31 
Data analysis
For blood flow measurements, multiple experimental groups were compared by analysis of variance followed by Tukey post hoc analysis. For measurements of cortical neuron loss after endothelin-1 treatment, visualized by polyadenylated mRNA fluorescence in situ hybridization staining, estimates of percentage cell loss and per cent of area in which cell loss occurred were performed by evaluating the entire cerebral cortex in the tissue slice at 610. Cell loss was confirmed by viewing at 640 to distinguish cell loss from weak staining. The per cent of damaged area and of cell loss were both compared by analysis of variance followed by Tukey post hoc if necessary. The majority of results reported here are descriptive and based on three-dimensional reconstruction of tissue using an ApoTome-equipped microscope as previously described. 16, 33 Stacks of optically sectioned 
Results
Endothelin-1 and cerebral blood flow Figure 1 shows the result of local cerebral blood flow measurements in cerebral cortex and hippocampus in vehicle-treated and from 100 to 800 pg endothelin-1 administration. The 100-pg dose had no effect on blood flow in either region. A dose-dependent decrease in blood flow was observed from 200 to 800 pg endothelin-1. Blood flow was reduced by onethird and one-half with 200 and 400 pg endothelin-1, respectively, and no difference in decrease occurred between cerebral cortex or hippocampus. At 800 pg endothelin-1, cortical blood flow was decreased 80%, and hippocampal blood flow was decreased 94%. The graded decrease in blood flow led us to hypothesize that we would observe graded effects in brain tissue injury following endothelin-1 administration. However, results from our in situ studies described below indicated that the graded changes in blood flow were only apparent, and likely represented averages of inhomogeneous patterns of blood flow reduction. Figure 2 shows coronal sections of the endothelin-1 injection site at 20.8 mm posterior to Bregma, and the level of brain section chosen for evaluation at 23.0 mm posterior to Bregma containing the dorsal hippocampus. Ventral and lateral injection coordinates are indicated by arrows on the left image. Slices were evaluated 2.2 mm posterior to the site of endothelin-1 injection to avoid damage due to the injection site. We excluded slices showing cortical damage that had obviously resulted from the injection tract into the brain. As described below, damage occurred heterogeneously throughout the entire area of the cerebral cortex. Table 1 lists averages for the total area of cerebral cortex displaying evidence of cell damage or death following endothelin-1 injection, as evaluated by polyadenylated mRNA fluorescence in situ hybridization staining. Table 1 also lists the decrease in the number of cells, expressed as a percentage of controls, in areas displaying cellular damage. The criteria for designating an area as 'damaged' included: (i) decreased density of cells; (ii) altered cell morphology from controls, usually, but not exclusively, in the form of cell shrinkage and distortion; and (iii) a significant decrease in cell staining compared to undamaged areas. The values in Table 1 are only rough indicators of cell damage because of the heterogeneity we report below.
Endothelin-1-induced cortical damage
There was a trend toward a dose-dependent increase in the area of cerebral cortex showing cell damage from 200 to 800 pg endothelin-1. However, for 200 pg only one of three animals showed evidence of damage at 23.0 mm posterior to Bregma. It is possible that other slices in the 200-pg samples showed damage, but we did not observe them due to our adherence to fixed coordinates for analysis. All of the 400-and 800-pg endothelin-1-treated animals showed evidence of cerebral cortical damage at 23.0 mm posterior to Bregma. The respective per cent of area damaged did not clear statistically because the 400-pg samples showed wide variation, ranging from 18 to 63% of cortical area damaged. The 800-pg samples showed less variation, ranging from 60 to 80% damaged area. For all three experimental groups, the percentage decreases in cells within the damaged areas averaged about 50% and there was no statistical difference amongst the groups.
Assessment of cortical histology after endothelin-1 treatment
Histological assessment of cortical damage by polyadenylated mRNA staining showed the heterogeneity in damage distribution. Figure 3 shows polyadenylated mRNA staining for each endothelin-1 doses under both low (610) and high (640) power objectives. The 100-pg group was excluded from polyadenylated mRNA staining because this group showed no decrease in cerebral blood flow (Fig. 1) . Figure 3 includes the single 200-pg endothelin-1-treated animal that displayed cortical damage at the slice level we evaluated (see also Fig. 4 ).
Non-ischemic control layer II cortical neurons (Fig. 3B) had the same three general features of polyadenylated mRNA staining we reported previously for hippocampal neurons: 16 (i) diffuse and relatively homogeneous polyadenylated mRNA staining throughout the entire cytoplasm; (ii) occasional small and circular intense polyadenylated mRNA cytoplasmic staining that we previously showed were stress granules 16 (e.g., Fig. 5A , white arrows); and (iii) the presence, inside the area of the nucleus, of several intense, roughly circular structures ranging from 0.5 to 1 mm ('nuclear speckles', see below) against a weak background of diffuse polyadenylated mRNA staining.
As can be seen from the progression of images in Fig. 2 , layers II and III of the cerebral cortex were most strongly affected. The 200-pg sample showed decreased cell density and cell shrinkage ( Fig. 2C and D) as compared to controls ( Fig. 2A and B) . The 400-pg samples showed greater numbers of shrunken cells and areas devoid of cell staining. In the 800-pg samples, the damage extended into other cerebral cortical layers, and the areas devoid of cell staining were generally larger than the 400-pg group. Occasionally, microclots were observed in which red blood cells trapped in capillaries were stained by the poly-T probe (Fig. 3G, arrows) .
With respect to polyadenylated mRNA staining at a high magnification, we did not observe mRNA granules in any of the neurons following any dose of endothelin-1. Instead we observed one of two general patterns. In the first, polyadenylated mRNA staining of shrunken and distorted cells was reminiscent of that of controls with an apparently homogenous cytoplasm and intense nuclear polyadenylated mRNA staining ( Fig. 3D and F, arrows) . However, in the second polyadenylated mRNA staining pattern, we observed in many cases that cells were devoid of nuclear polyadenylated mRNA staining and that such cells, though distorted to some extent, were generally not shrunken (Fig. 3H, arrows) .
Loss of polyadenylated mRNA nuclear staining after endothelin-1 treatment A more detailed study of polyadenylated mRNA staining associated with cell loss is provided in Fig. 4 . The single 200-pg sample that displayed damage proved fortuitous for this purpose due to the lesser complexity of its damage distribution compared to any of the 400-or 800-pg endothelin-1 samples. Figure 4A shows a photomontage of a portion of left hemisphere cortex marked by the red box in the inset. This montage shows two clearly distinguishable areas of damage (A and B in Fig. 4A ). The discreet regions of cortical damage shown in the montage of Fig. 4A suggests the damaged areas experienced a substantial decrease in blood flow compared to surrounding regions.
Area A appeared to be the epicenter of damage and was distinguished by a wholesale loss of neuronal staining throughout layers II and III. Neurons detectable in area A were shrunken and distorted (Fig. 3F) . Area B occurred on either side of area A. In area B, while the cell density was lower than the surrounding undamaged areas, high power magnification revealed that neurons in area B consisted of two readily identifiable populations: (i) neurons containing the polyadenylated mRNA nuclear staining as seen in controls; and (ii) neurons that lacked the nuclear polyadenylated mRNA staining (Fig. 4B) . We 16 and others 35 have observed prominent 'nuclear speckles' of polyadenylated mRNA staining in the nucleus of neurons. There are typically 3-6 of these nuclear speckles visible in the nucleus as intensely stained, roughly ovoid (elliptical or circular in cross-section) structures 1/2 to 1 mm in diameter. In all likelihood, these represent areas of concentrated mRNA transcription and processing, in which the polyadenylated tail has been added to nascent mRNA transcripts before their exit from the nucleus. When orthographic projections (Fig. 4B ) and threedimensional volumetric reconstructions (Fig. 4C-G ) of area B were generated from 663 oil immersion image stacks (n560 slices, z depth521 mm), some neurons indeed showed lack of nuclear speckles and a clear decrease of nuclear polyadenylated staining (Fig. 4C, asterisks) .
To get a more accurate three-dimensional impression, isosurface renderings that convert the volumetric data to surfaces was performed (Fig. 4D-G) . The isosurface render of Fig. 4C is shown in Fig. 4D . Blow-ups of the neurons contained in boxes labeled e, f and g are shown in Fig. 4E -G, respectively. The neurons in Fig. 4E -G appeared to represent a continuum of nuclear polyadenylated mRNA staining. Where the neurons in Fig. 4E showed normal nuclear polyadenylated mRNA staining with nuclear speckles, the total nuclear polyadenylated mRNA staining was less in neurons of Fig. 4F , and absent in the neurons of Fig. 4G . However, as seen in the surface reconstruction of Fig. 4F , the apparent polyadenylated mRNA nuclear staining was in fact the cytoplasm outside of the nucleus, and the volume inside of the nucleus was devoid of polyadenylated mRNA staining.
Cortical polyadenylated mRNA staining following focal cerebral ischemia
We present here, to the best of our knowledge, the first description of polyadenylated mRNA staining following focal cerebral ischemia. Our description here is abbreviated and a more thorough study will be forthcoming.
36 Figure 5A shows an orthographic projection (four slices, z depth51.4 mm) of layer II neurons in sham-operated controls. Figure 5B shows a three-dimensional volumetric reconstruction of a single layer II neuron from a sham animal. Here, the cytoplasmic polyadenylated mRNA staining is false colored in green hues, and the polyadenylated mRNA nuclear staining in orange hues. The cytoplasmic polyadenylated mRNA staining is homogenous and smooth, similar to what we previously reported in control hippocampal neurons. 16 Following 4 hours of middle cerebral artery occlusion-induced unilateral ischemia, we observed prominent mRNA granules in the cytoplasm of layer II neurons of the ipsilateral cerebral cortex (Fig. 5C ). The cortical area from which Fig. 5C is derived is shown by the box in the green area of Fig. 5E . The green area marks the extent for which neurons, mainly of layers II and III, showed mRNA granules. A volumetric representation of a 4-hour ischemic layer II neuron is shown in Fig. 5D (z depth51.4 mm). While the nuclear staining (orange) is similar to sham-operated controls, the polyadenylated mRNA cytoplasmic distribution can be seen to form a prominent and distinct granular distribution, the mRNA granules. As can be readily seen comparing Fig. 5C to 5A, there was no change in nuclear polyadenylated mRNA staining after 4-hour middle cerebral artery occlusion as compared to controls. While polyadenylated mRNA staining revealed shrunken and distorted neurons in what would have become the core area in layer VI (inset, Fig. 5C ; image derived from the area designated by the box in the red area of Fig. 5E ), we did not observe a lack of 2,3,5-triphenyltetrazolium chloride staining in the 4-hour middle cerebral artery occlusion samples (Fig. 5F, 4hI) . However, 2,3,5-triphenyltetrazolium chloride staining for the 4-hour middle cerebral artery occlusion samples did appear somewhat paler than sham operated controls (non-ischemic controls, Fig. 5F ) suggesting evolution of a core region. Following 2-hour middle cerebral artery occlusion and 24-hour reperfusion in the Long-Evans rats, a core area devoid of 2,3,5-triphenyltetrazolium chloride staining did occur (data not shown).
Cortical polyadenylated mRNA staining following global ischemia and reperfusion
Our initial report of mRNA granules 16 used a normothermic 10-minute global ischemia period and extensively described hippocampal neurons. In that report, we mentioned the occurrence of mRNA granules in cortical neurons following 10 minutes of global ischemia but presented no data. Here, again to our knowledge, we present the first visualization of mRNA granules in cerebral cortical neurons of layer II of the rat following 10 minutes of global brain ischemia and 1 hour of reperfusion (Fig. 6A) . Essentially all neurons of layer II showed evidence of mRNA granules. Figure 6B and C shows volumetric renderings of a single neuron (36 slices, z depth512.6 mm), with the same false color scheme as used in Fig. 5 . Figure 6C is a 90u rotation about the x axis of Fig. 6B , showing almost the entirety of the neuron's cell body. The mRNA granules occupied the entire cytoplasm. The nuclear polyadenylated mRNA staining resembled that of controls (e.g., as in Fig. 5B ). was no evidence of a generalized decrease in nuclear polyadenylated mRNA staining. However, following 15 minutes of global ischemia and 60 minutes of reperfusion, layer II neurons took on a considerably different appearance (Fig. 6D) . The neurons were somewhat more distorted and shrunken relative to those after 10 minutes of global ischemia. There was not widespread loss of cortical neurons evident after 15 minutes of global brain ischemia and 60 minutes of reperfusion, as was seen with the endothelin-1 treatment. The cytoplasmic polyadenylated mRNA staining showed evidence of mRNA granulation. In addition, a clear decrease in nuclear polyadenylated mRNA staining was apparent in the 15-minute global brain ischemia and minute reperfusion group (compare Fig. 6A and D) . A three-dimensional volumetric rendering of a layer II neuron after 15 minutes of global brain ischemia and 60 minutes of reperfusion is shown in Fig. 6E (27 slices, z depth59.45 mm) in which the granular nature of the cytoplasmic polyadenylated mRNA staining is apparent. The accompanying isosurface rendering in Fig. 6F clearly shows the hollow nucleus of the neuron, resembling that seen following endothelin-1 treatment (compare Figs. 6F to 4F).
A gradation of loss of polyadenylated mRNA nuclear staining after 15 minutes of global ischemia
Careful z stack analysis of the 15-minute global brain ischemia and 60-minute reperfusion samples allowed us to discern a graded decrease in polyadenylated mRNA nuclear staining. Figure 7A shows a portion of an orthographic projection derived from a 44-slice z stack (z depth515.4 mm) of layer II neurons. The three neurons labeled b, c and d were captured at approximately the same z depth in this stack, and all three neurons displayed similar intensities of granulated cytoplasmic polyadenylated mRNA staining, so that differences in polyadenylated mRNA nuclear staining could not be attributed to the penetration depth of the probe. Three-dimensional volumetric reconstructions through the middle 5 mm of each neuron were constructed (Fig. 7B-1, C-1, and D-1) . The graded decrease in nuclear polyadenylated mRNA staining is readily visible in these crosssections, where a decrease in the staining intensity of the nuclear speckles is apparent. These impressions were substantiated by isosurface renderings where the cytoplasmic shell was rendered in a different color from the nuclear polyadenylated mRNA staining ( Fig. 7B-2, C-3 and D-2) . Here, the decrease in surface area of nuclear polyadenylated mRNA staining (the blue surface) is apparent. Figure 7B renderings to show how they register. Thus, the loss of nuclear polyadenylated mRNA staining formed a gradation that reflected a progressive decrease in the polyadenylated mRNA staining of the nuclear speckles.
Fluoro-Jade staining of samples
Fluoro-Jade staining is used as a marker of degenerating neurons. 37 We used Fluoro-Jade staining to further characterize cell injury phenotypes induced by endothelin-1 or brain ischemia (Fig. 8) . Surprisingly, blood vessels were a prominent staining target after endothelin-1 treatment (Fig. 8A and B) . Such blood vessel staining by Fluoro-Jade did not occur in the middle cerebral artery occlusion or global ischemia samples, suggesting that endothelin-1 acted as a stressor on vascular elements. High power photomicrographs of Fluoro-Jade stained blood vessels revealed a striated pattern suggestive of smooth muscle cells associated with cerebral arteries (Fig. 8B) , a well-established target of endothelin-1. 38 We also observed staining of nuclei in areas that were devoid of cell staining by polyadenylated mRNA fluorescence in situ hybridization. Figure 8C illustrates the patchy distribution of neuronal loss after 800 pg endothelin-1. The high-power photomicrograph of Fig. 8D shows a disintegrating neuropil with a 'spongy' appearance in which are embedded Fluoro-Jade responsive nuclei which are highly shrunken, again after 800 pg endothelin-1. These images resemble the core region of layer VI produced by 2 hours of middle cerebral artery occlusion ischemia followed by 24 hours of reperfusion (Fig. 8E) , in which the neuropil also appears 'spongy' and shrunken neuronal nuclei respond to Fluoro-Jade.
Finally, we consistently observed the nuclei of hippocampal CA1 neurons under the site of endothelin-1 injection to respond to Fluoro-Jade (Fig. 8F) . Interestingly, the Fluoro-Jade responsive CA1 neurons were devoid of nuclear polyadenylated mRNA staining (Fig. 8G) . However, adjacent CA1 neurons that were unresponsive to Fluoro-Jade (Fig. 8H) showed normal polyadenylated mRNA staining resembling control CA1. 16 
Discussion
In the present study, we have used high-resolution, polyadenylated mRNA staining as a type of 'functional' histological marker. We previously showed that the appearance of mRNA granules in post-ischemic neurons correlated with an inhibition of in vivo protein synthesis below control levels. 16 The mRNA granules also failed to colocalize with ribosomal protein S6, 16 a marker of the small ribosomal subunit, reinforcing the link between mRNA granules and protein synthesis inhibition.
We have suggested that the reversible inhibition of protein synthesis in post-ischemic neurons is a marker of the transient genetic reprogramming of post-ischemic neurons to a stress response phenotype to abate and repair damage wrought by ischemia and reperfusion. 17 Thus, we undertook the present set of studies to assess for the presence of mRNA granules as a marker of stress response reprogramming under a wider variety of ischemic conditions including longer global ischemia, focal ischemia, and following endothelin-1 treatment.
mRNA granules
Consistent with our previous observations, 16 mRNA granules occurred in the neurons following 10 minutes of global brain ischemia and 60 minutes of reperfusion, and also following 4 hours of middle cerebral artery occlusion ischemia with no reperfusion. In neither of these conditions was a change in nuclear polyadenylated mRNA staining apparent. The presence of neuronal mRNA granules under these two conditions suggests these neurons are experiencing protein synthesis inhibition in the service of reprogramming to a stress response phenotype. This conclusion is supported by: (i) the fact that 10 minutes of global ischemia or 2 hours of middle cerebral artery occlusion ischemia and 24 hours of reperfusion does not induce widespread cortical neuronal death; 39 and (ii) that the location of the mRNA granule-containing neurons following 4 hours of middle cerebral artery occlusion (Fig. 5E , green area) is well outside of the core region, consistent with previous studies showing HSP70, FOS and other stress response protein expression in this cortical area following focal ischemia, [40] [41] [42] We also observed mRNA granules after 15 minutes of global brain ischemia and 60 minutes of reperfusion which in some cases cooccurred with loss of nuclear polyadenylated mRNA staining (Figs. 6D-F and 7) . We consider the significance of this observation below.
Endothelin-1, apparent graded blood flow reduction, and mRNA granules
Inhibition of protein synthesis has been shown to occur after blood flow reductions to about 0.55 ml/g/ minute, 43 which we observed at 400 pg endothelin-1 (Fig. 1) . We sought to confirm whether mRNA granule formation occurred at the threshold of protein synthesis inhibition. However, we did not observe mRNA granules at any endothelin-1 dose.
Our histological results suggest an explanation for this apparent discrepancy. We observed discreet areas of damaged cerebral cortex interspersed amongst regions showing little or no damage (e.g., Fig. 4A ), and damaged area showed a trend of increasing as a function of endothelin-1 dose (Table 1) . Such VOL. 33 NO. 2 heterogeneous damage implies that blood flow reduction was equally heterogeneous. The apparent graded decrease in blood flow with endothelin-1 dose can be explained by an increasing recruitment of cortical areas with little or no blood flow, corresponding to the increased area of cortical damage (Table 1 ). The magnetic resonance imaging measurements would then represent averages of these heterogeneous blood flow patterns over the volumes used for detection. Mechanistically, this would imply that endothelin-1 affected discreet blood vessels differentially. Once a vessel became constricted by endothelin-1, blood flow would be reduced in that vessel, which may have limited the bulk flow of endothelin-1 throughout the vasculature.
Thus, endothelin-1 proved unsuitable to generate a homogeneous graded decrease in cerebral blood flow, preventing us from using endothelin-1 as a means to assess if the blood flow threshold for the formation of mRNA granules was the same as that which induces the inhibition of protein synthesis. While we were unsuccessful in this regard, the heterogeneous patterns of endothelin-1 damage proved fortuitous by generating a novel pattern of loss of nuclear polyadenylated mRNA staining in some post-ischemic neurons.
Loss of polyadenylated mRNA nuclear staining
We report here the novel observation of the loss of polyadenylated mRNA nuclear staining. This occurred after endothelin-1 treatment at all doses (Figs. 3H, 4F , and 4G) but cannot be specific to endothelin-1 treatment because it also occurred following 15 minutes of global brain ischemia and 60 minutes of reperfusion ( Fig. 6D-F) . There are at least three possible functional interpretations of this observation and these are not necessarily mutually exclusive. A graded loss of nuclear speckles could represent: (i) a graded decrease in transcription of new mRNAs, and/or (ii) a graded decrease in processing of nascent transcripts (e.g., addition of the polyadenylated tail), and/or (iii) a graded increase in degradation of nascent transcripts within the nucleus. The present study provides no direct means to distinguish these possibilities.
There is a surprising dearth of studies of overall mRNA metabolism following cerebral ischemia and reperfusion. Yanagihara observed suppression of RNA polymerase activity following 3 hours of reperfusion after 30 minutes of carotid artery occlusion in gerbils. 44 Maruno and Yanagihara reported loss of total mRNA at 1 day following 10 minutes of carotid artery occlusion in gerbils. 45 However, Matsumoto et al. failed to find a decrease in nuclear mRNA during reperfusion after 15 minutes of hindbrain ischemia. 46 Application of biochemical methods in the present study would have been problematic given the heterogeneous distribution of the cells showing loss of polyadenylated mRNA nuclear staining dispersed amongst cells with polyadenylated mRNA nuclear staining (e.g. Fig. 4A and B) . There is abundant evidence of DNA alterations following brain ischemia and reperfusion including fragmentation 47, 48 and chromatin condensation. [49] [50] [51] Loss of DNA structural and functional integrity would be expected to interfere with mRNA transcription and/or processing. It is therefore possible that loss of nuclear polyadenylated mRNA staining is related to alterations in nuclear DNA in postischemic neurons. The details of this relationship remain to be determined.
Polyadenylated mRNA staining in relation to post-injury neuronal phenotypes Different classes of necrotic post-ischemic phenotypes have been defined on the basis of morphological criteria, for which ischemic cell change is the most prevalent. 52 Ischemic cell change is characterized by shrinkage of the nucleus and cytoplasm, cellular distortion, acidophilia and nuclear pyknosis. 52, 53 Following endothelin-1 treatment, the areas we designated as having the greatest degree of damage showed abundant 'apparent' ischemic cell change. We say 'apparent' because we did not here use hematoxylin and eosin staining, but base this identification on the fact that neurons were shrunken and distorted ( Fig. 3D and F) . On this basis we also saw evidence of occasional ischemic cell change following 4 hours of focal ischemia (arrows, Fig. 4C ) or after 15 minutes of global brain ischemia and 60 minutes of reperfusion (arrow, Fig. 6D ). Generally, the highly shrunken ischemic cell change neurons had a polyadenylated mRNA staining pattern reminiscent of controls, albeit in a distorted fashion. Given the shrunken nature of the cell cytoplasm, we could not unambiguously determine if the ischemic cell change cells contained cytoplasmic mRNA granules. However, the shrunken cells generally retained polyadenylated mRNA nuclear staining resembling nuclear speckles (e.g., arrows, Fig. 3D and F) . In contrast to cells apparently in the ischemic cell change stage, polyadenylated mRNA staining distinguished other cell phenotypes that were not massively shrunken, and which may have been previously described using other staining methods. For example, Petito et al., using 10 minutes of four-vessel occlusion global ischemia in rats, described post-ischemic changes in CA1 at 1 day of reperfusion with 'mild nuclear swelling'. 54 However, this conclusion was qualitative and nuclear diameters were not measured. We observed that mRNA granulation resulted in an apparent condensation of the cytoplasmic area (compare Fig. 5A to 5C), with a resulting increase in total cell area taken up by the nucleus, suggesting Petito et al. may have observed cells with condensed cytoplasm instead of 'mild nuclear swelling'. Rosenblum also describes eosinophilic neurons that are not shrunken, but have distinguishable changes such as altered nuclear appearance. 53 High-resolution analysis using polyadenylated mRNA staining provides a new window onto such previously identified morphological changes in non-shrunken post-ischemic neurons.
Relationships between polyadenylated mRNAidentified phenotypes
In the present study, we observed five distinguishable phenotypes in layer II cortical neurons. These are summarized and labeled as phenotypes A-E in Fig. 9 . VOL. 33 NO. 2 Do these phenotypes reflect different stages of the same injury process or different and parallel processes?
Phenotypes B and C appear to reflect a phenotypic sequence that occurred with increasing ischemic intensity. Ten minutes of ischemia followed by 60 minutes of reperfusion and 4 hours of middle cerebral artery occlusion ischemia and 24 hours of reperfusion does not kill layer II neurons, 39 consistent with our interpretation that mRNA granule formation (phenotype B) reflects the shift to a protective stress response phenotype. 17 With 15 minutes of global brain ischemia and 60 minutes of reperfusion, loss of polyadenylated mRNA nuclear staining occurred in addition to mRNA granule formation (phenotype C). Since 15 minutes of global ischemia is more intense of an insult than 10 minutes, loss of polyadenylated mRNA nuclear staining is obviously an indicator of a greater degree of insult than the formation of the mRNA granules. The endothelin-1 samples showed that loss of nuclear polyadenylated mRNA staining can occur in the absence of mRNA granule formation (phenotype D). Such a 'double dissociation' indicates mRNA granules and loss of polyadenylated mRNA staining are mediated by independent processes. Since loss of polyadenylated mRNA nuclear staining occurred with the more intense global insult, loss of polyadenylated mRNA nuclear staining may, as discussed above, be a marker of cellular damage, as opposed to mRNA granules marking a protective response.
A key issue unresolved by the present study is whether phenotypes C and D, both of which displayed loss of nuclear polyadenylated mRNA staining, are reversible phenotypes that can recover, or if these are early stages of non-shrunken neurons irreversibly committed to cell death. Lack of loss of nuclear polyadenylated mRNA staining in the apparent ischemic cell change cells (phenotype E, Fig. 9 ), and their co-occurrence with the other phenotypes, suggests that processes leading to ischemic cell change occur in parallel to those leading to the other nonshrunken phenotypes. The delayed neuronal death of hippocampal CA1 neurons does not include the loss of polyadenylated mRNA nuclear staining. 16 Thus, while loss of nuclear polyadenylated mRNA staining may be a marker of cell damage, it is not obligate for the delayed neuronal death of CA1 neurons. If loss of nuclear polyadenylated mRNA staining is a marker of eventual cell death, it would represent a different mode of cell death from CA1 delayed neuronal death. Future studies must address the relationship between loss of nuclear polyadenylated mRNA staining and cell death. Phenotype A is the normal polyadenylated mRNA staining pattern of unaffected (control) neurons. Phenotype B showed only cytoplasmic mRNA granules. Phenotype C showed mRNA granules in the cytoplasm and loss of nuclear polyadenylated mRNA staining. Phenotype D showed no mRNA granules and loss of nuclear polyadenylated mRNA staining. Phenotype E consisted of shrunken 'apparent' ischemic cell change cells. Experimental group ('Conditions') abbreviations as defined in the text. For cytoplasmic polyadenylated mRNA staining, 'homogeneous' refers to the diffuse cytoplasmic polyadenylated mRNA staining excluding stress granules and 'granular' refers to mRNA granules. 'Speckles' refers to nuclear speckles identified by polyadenylated mRNA staining. 'na', not applicable; 'nd', not determined. 
Conclusion
The present study evaluated polyadenylated mRNA staining as a 'functional' histological marker of postischemic phenotypes. It further illustrated the utility of polyadenylated mRNA fluorescence in situ hybridization staining for characterizing the response of neurons under a variety of injury conditions. We were unable to use endothelin-1 intraventricular injection to determine the threshold of mRNA granule formation. However, we identified two previously undescribed post-ischemic phenotypes, both characterized by loss of nuclear polyadenylated mRNA staining (Fig. 9 , phenotypes C and D). The functional significance and contribution, if any, to post-ischemic cell death remains to be determined. Nonetheless, the present work provides additional insight into the complexity of post-ischemic phenotypes, and supports a notion whereby post-ischemic phenotypes derive from a competition between protective stress responses and destructive damage mechanisms. VOL. 33 NO. 2
